- Home
- CYRX vs ARCT Comparison
CYRX vs ARCT Comparison
Compare CYRX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- ARCT
- Stock Information
- Founded
- CYRX 1999
- ARCT 2013
- Country
- CYRX United States
- ARCT United States
- Employees
- CYRX N/A
- ARCT N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- ARCT Health Care
- Exchange
- CYRX Nasdaq
- ARCT Nasdaq
- Market Cap
- CYRX 277.5M
- ARCT 298.3M
- IPO Year
- CYRX N/A
- ARCT N/A
- Fundamental
- Price
- CYRX $6.37
- ARCT $12.29
- Analyst Decision
- CYRX Strong Buy
- ARCT Strong Buy
- Analyst Count
- CYRX 8
- ARCT 8
- Target Price
- CYRX $10.75
- ARCT $52.33
- AVG Volume (30 Days)
- CYRX 467.6K
- ARCT 476.9K
- Earning Date
- CYRX 08-05-2025
- ARCT 08-04-2025
- Dividend Yield
- CYRX N/A
- ARCT N/A
- EPS Growth
- CYRX N/A
- ARCT N/A
- EPS
- CYRX N/A
- ARCT N/A
- Revenue
- CYRX $232,134,000.00
- ARCT $143,680,000.00
- Revenue This Year
- CYRX N/A
- ARCT N/A
- Revenue Next Year
- CYRX $9.63
- ARCT $34.79
- P/E Ratio
- CYRX N/A
- ARCT N/A
- Revenue Growth
- CYRX 11.75
- ARCT 15.38
- 52 Week Low
- CYRX $4.58
- ARCT $8.04
- 52 Week High
- CYRX $9.93
- ARCT $28.05
- Technical
- Relative Strength Index (RSI)
- CYRX 48.30
- ARCT 49.59
- Support Level
- CYRX $6.53
- ARCT $12.01
- Resistance Level
- CYRX $6.98
- ARCT $13.42
- Average True Range (ATR)
- CYRX 0.47
- ARCT 0.82
- MACD
- CYRX -0.01
- ARCT -0.05
- Stochastic Oscillator
- CYRX 56.38
- ARCT 25.70
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.